In vivo inactivation of erythrocyte S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine in adenosine deaminase-deficient patients.

M S Hershfield; N M Kredich; D R Ownby; H Ownby; R Buckley

doi:10.1172/JCI109367

Find articles by Hershfield, M. in: PubMed | Google Scholar

Find articles by Kredich, N. in: PubMed | Google Scholar

Find articles by Ownby, D. in: PubMed | Google Scholar

Find articles by Ownby, H. in: PubMed | Google Scholar

Find articles by Buckley, R. in: PubMed | Google Scholar

Published in Volume 63, Issue 4 on April 1, 1979
J Clin Invest. 1979;63(4):807–811. https://doi.org/10.1172/JCI109367.
© 1979 The American Society for Clinical Investigation

Published April 1, 1979 - Version history

The cytotoxic nucleoside 2'-deoxyadenosine is excreted in excessive amounts by individuals with genetic deficiency of adenosine deaminase, and may be in part responsible for the severe combined immune dysfunction from which they suffer. Earlier studies from this laboratory showed that 2'-deoxyadenosine causes the irreversible inactivation of the enzyme S-adenosylhomocysteine hydrolase by an active site-directed, "suicide-like" process. In this communication we have demonstrated similar inactivation of S-adenosylhomocysteine hydrolase in hemolysate and in intact erythrocytes, as well as a striking deficiency of S-adenosylhomocysteine hydrolase activity in the erythrocytes of three adenosine deaminase-deficient patients. In vivo suicide-like inactivation of S-adenosylhomocysteine hydrolase by 2'-deoxyadenosine may contribute to the cytotoxicity of 2'-deoxyadenosine and to the immune dysfunction in adenosine deaminase deficiency.

Click on an image below to see the page. View PDF of the complete article